top of page

Ethiopia

The SeroSelectTB test will be evaluated at 57 primary healthcare units in six Woredas of the West Gojjam Zone of the Amhara Region, Ethiopia. TB suspects self-reporting to the study sites will be randomised in two arms: standard-of-care or SeroSelectTB. In Ethiopia, 3198 TB suspects will be enrolled in each study arm.

 

This section will be updated as the clinical trial proceeds.

Walk Through Site Video - August 2021

bottom of page